Okamoto A - Search Results

1

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease.

Wilson MK, Pujade-Lauraine E, Aoki D, Mirza MR, Lorusso D, Oza AM, du Bois A, Vergote I, Reuss A, Bacon M, Friedlander M, Gallardo-Rincon D, Joly F, Chang SJ, Ferrero AM, Edmondson RJ, Wimberger P, Maenpaa J, Gaffney D, Zang R, Okamoto A, Stuart G, Ochiai K; participants of the Fifth Ovarian Cancer Consensus Conference. Wilson MK, et al. Among authors: okamoto a. Ann Oncol. 2017 Apr 1;28(4):727-732. doi: 10.1093/annonc/mdw663. Ann Oncol. 2017. PMID: 27993805 Free PMC article.

2

Combination therapy with podophyllin and vidarabine for human papillomavirus positive cervical intraepithelial neoplasia.

Okamoto A, Woodworth CD, Yen K, Chung J, Isonishi S, Nikaido T, Kiyokawa T, Seo H, Kitahara Y, Ochiai K, Tanaka T. Okamoto A, et al. Oncol Rep. 1999 Mar-Apr;6(2):269-76. doi: 10.3892/or.6.2.269. Oncol Rep. 1999. PMID: 10022988 Clinical Trial.

3

Allelic imbalance and mutations of the PTEN gene in ovarian cancer.

Saito M, Okamoto A, Kohno T, Takakura S, Shinozaki H, Isonishi S, Yasuhara T, Yoshimura T, Ohtake Y, Ochiai K, Yokota J, Tanaka T. Saito M, et al. Among authors: okamoto a. Int J Cancer. 2000 Jan 15;85(2):160-5. Int J Cancer. 2000. PMID: 10629071 Free article.

4

Telomerase activity in gynecological tumors.

Sakamoto M, Toyoizumi T, Kikuchi Y, Okamoto A, Nakayama H, Aoki D, Yamamoto K, Hata H, Sugishita T, Tenjin Y. Sakamoto M, et al. Among authors: okamoto a. Oncol Rep. 2000 Sep-Oct;7(5):1003-9. doi: 10.3892/or.7.5.1003. Oncol Rep. 2000. PMID: 10948330

5

Low specificity of cytokeratin 19 mRNA expression in the peripheral blood cells from patients with ovarian tumors.

Takano H, Okamoto A, Fukushima K, Ochiai K, Tanaka T. Takano H, et al. Among authors: okamoto a. Oncol Rep. 2000 Sep-Oct;7(5):1023-5. doi: 10.3892/or.7.5.1023. Oncol Rep. 2000. PMID: 10948333

6

Identification by cDNA microarray of genes involved in ovarian carcinogenesis.

Ono K, Tanaka T, Tsunoda T, Kitahara O, Kihara C, Okamoto A, Ochiai K, Takagi T, Nakamura Y. Ono K, et al. Among authors: okamoto a. Cancer Res. 2000 Sep 15;60(18):5007-11. Cancer Res. 2000. PMID: 11016619

7

A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis.

Yamamoto K, Okamoto A, Isonishi S, Ochiai K, Ohtake Y. Yamamoto K, et al. Among authors: okamoto a. Biochem Biophys Res Commun. 2001 Feb 2;280(4):1148-54. doi: 10.1006/bbrc.2001.4250. Biochem Biophys Res Commun. 2001. PMID: 11162647

8

Absence of p51 alteration in human ovarian cancer.

Shinozaki H, Okamoto A, Shimizu K, Saito M, Yokota J, Ochiai K. Shinozaki H, et al. Among authors: okamoto a. Int J Oncol. 2001 Mar;18(3):549-52. Int J Oncol. 2001. PMID: 11179485

9

Heat shock protein 27 was up-regulated in cisplatin resistant human ovarian tumor cell line and associated with the cisplatin resistance.

Yamamoto K, Okamoto A, Isonishi S, Ochiai K, Ohtake Y. Yamamoto K, et al. Among authors: okamoto a. Cancer Lett. 2001 Jul 26;168(2):173-81. doi: 10.1016/s0304-3835(01)00532-8. Cancer Lett. 2001. PMID: 11403922

10

Reduced expression of MYO18B, a candidate tumor-suppressor gene on chromosome arm 22q, in ovarian cancer.

Yanaihara N, Nishioka M, Kohno T, Otsuka A, Okamoto A, Ochiai K, Tanaka T, Yokota J. Yanaihara N, et al. Among authors: okamoto a. Int J Cancer. 2004 Oct 20;112(1):150-4. doi: 10.1002/ijc.20339. Int J Cancer. 2004. PMID: 15305387 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,540 results

Search Page